ECHR finds Romania in violation of Human Rights, discriminating against applicants on grounds of their sexual orientation
SOGI Newsroom Strasbourg 1 June 2021 Augmenter la taille du texte Imprimer la page Imprimer en PDF
In todayâs judgment in the case of Accept and others v. Romania, the European Court of Human Rights found a violation of Article 14 regarding prohibition of discrimination in conjunction with the right to respect for private life and freedom of assembly. The case concerned a demonstration that occurred at a public screening of a movie portraying a same-sex family during the applicant associationâs LGBT History Month in February 2013, on the premises of a public museum. The event was interrupted by a group of protesters who entered the venue shouting homophobic remarks, insulting and threatening the participants. The Court found that the authorities had failed to offer applicantsâ
Muscat: The Supreme Committee on Wednesday also has decided to open beaches and public parks with an emphasis on avoiding gatherings and adhering to all preventive measures. The Committee also has decided to allow practice of group sports activities in open spaces, adhering to all precuations. Gyms across the Sultanate can also reopen at 50% of their.
What does a former Seema Verma advisor think of Brooks-LaSure, the incoming CMS administrator?
What does a former Seema Verma advisor think of Brooks-LaSure, the incoming CMS administrator?
To know how Chiquita Brooks-LaSure will lead the Centers for Medicare and Medicaid Services, we sat down with Matthew Hittle, a former senior adviser to Seema Verma, who led the agency under the former president.
Shares0
HHS Secretary Xavier Becerra and Chiquita Brooks-LaSure at her swearing in ceremony on May 27.
Last week, U.S. Senators narrowly confirmed Chiquita Brooks-LaSure as administrator of the Centers for Medicare & Medicaid Services (CMS), entrusting this veteran health policy advisor with the critical role that has been vacant since Seema Verma stepped down in January.
The vaccines include Sinopharm, Johnson & Johnson, AstraZeneca Covishield, AZD 12225-Korea AstraZeneca, and Pfizer BioNTech, the Xinhua news agency reported.Kenn